2-phenylbenzimidazole has been researched along with Chondrosarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CS; Huang, YL; Liu, JF; Tang, CH; Yang, WH | 1 |
1 other study(ies) available for 2-phenylbenzimidazole and Chondrosarcoma
Article | Year |
---|---|
1-benzyl-2-phenylbenzimidazole (BPB), a benzimidazole derivative, induces cell apoptosis in human chondrosarcoma through intrinsic and extrinsic pathways.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Bone Neoplasms; Cells, Cultured; Chondrosarcoma; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Signal Transduction; Xenograft Model Antitumor Assays | 2012 |